Editorial: Host-microbiota immuno-interactions for personalized microbial therapeutics, volume II
-
By
-
Shashank Gupta
-
Sunil Kumar Raghav
-
Nar Singh Chauhan
-
July 7, 2026
-
Clinical Scorecard: Editorial: Immunological Interactions Between Host and Microbiota for Tailored Microbial Therapies, Volume II
At a Glance
| Category | Detail |
|---|
| Condition | Host-microbiota immuno-interactions |
| Key Mechanisms | Microbial metabolites and structural molecules influence immune responses and maintain immune homeostasis. |
| Target Population | Individuals with dysbiosis or immune-related conditions. |
| Care Setting | Research and clinical settings focusing on personalized microbial therapeutics. |
Key Highlights
- Host-microbiota interactions are crucial for immune system education and disease susceptibility.
- Dysbiosis can lead to pathological conditions and serve as biomarkers for disease risk.
- Microbiome-informed approaches can enhance clinical management and disease prediction.
Guideline-Based Recommendations
Diagnosis
- Utilize gut microbial profiles as biomarkers for risk stratification in critically ill patients.
Management
- Implement microbiome-guided probiotics and prebiotics for personalized therapeutic strategies.
Monitoring & Follow-up
- Integrate microbiota profiles with clinical indicators for disease progression monitoring.
Risks
- Dysbiosis is associated with increased risk for various diseases, including infections and metabolic disorders.
Patient & Prescribing Data
Patients with conditions influenced by gut microbiota, such as obesity, liver disease, and respiratory infections.
Postbiotic approaches and next-generation probiotics may offer therapeutic benefits.
Clinical Best Practices
- Consider the role of gut microbiota in immune modulation when designing treatment plans.
- Employ systems biology approaches to develop precision diagnostic strategies.
Related Resources & Content
